Polarean Imaging plc operates as a specialized entity within the medical imaging sector, focusing on integrated drug-device solutions. The company extends its services across international markets, including the United States, Canada, Germany, and the United Kingdom. At its core, Polarean is engaged in the creation and market introduction of advanced gas polarizer systems and associated ancillary instruments. A significant aspect of their innovation lies in developing specialized equipment that enhances conventional magnetic resonance imaging (MRI) machines, enabling them to perform advanced functional pulmonary imaging. The company distinguishes itself by specializing in the application of hyperpolarized xenon gas (129Xe) as a unique imaging agent. This technology allows for the detailed visualization of regional ventilation and gas exchange within the lungs, particularly in the smallest airways, the interface between the lung tissue and the bloodstream, and the pulmonary vasculature, thereby offering a novel diagnostic method. Furthermore, Polarean Imaging plc is actively involved in the design and manufacturing of the specific MRI radiofrequency coils that are indispensable for imaging 129Xe within an MRI system. Established in 2016, the company's base of operations is located in Durham, North Carolina.
—
Polarean Imaging plc operates as a specialized entity within the medical imaging sector, focusing on integrated drug-device solutions. The company extends its services across international markets, including the United States, Canada, Germany, and the United Kingdom. At its core, Polarean is engaged in the creation and market introduction of advanced gas polarizer systems and associated ancillary instruments. A significant aspect of their innovation lies in developing specialized equipment that enhances conventional magnetic resonance imaging (MRI) machines, enabling them to perform advanced functional pulmonary imaging. The company distinguishes itself by specializing in the application of hyperpolarized xenon gas (129Xe) as a unique imaging agent. This technology allows for the detailed visualization of regional ventilation and gas exchange within the lungs, particularly in the smallest airways, the interface between the lung tissue and the bloodstream, and the pulmonary vasculature, thereby offering a novel diagnostic method. Furthermore, Polarean Imaging plc is actively involved in the design and manufacturing of the specific MRI radiofrequency coils that are indispensable for imaging 129Xe within an MRI system. Established in 2016, the company's base of operations is located in Durham, North Carolina.
—
Daily adjusted close
Polarean Imaging plc operates as a specialized entity within the medical imaging sector, focusing on integrated drug-device solutions. The company extends its services across international markets, including the United States, Canada, Germany, and the United Kingdom. At its core, Polarean is engaged in the creation and market introduction of advanced gas polarizer systems and associated ancillary instruments. A significant aspect of their innovation lies in developing specialized equipment that enhances conventional magnetic resonance imaging (MRI) machines, enabling them to perform advanced functional pulmonary imaging. The company distinguishes itself by specializing in the application of hyperpolarized xenon gas (129Xe) as a unique imaging agent. This technology allows for the detailed visualization of regional ventilation and gas exchange within the lungs, particularly in the smallest airways, the interface between the lung tissue and the bloodstream, and the pulmonary vasculature, thereby offering a novel diagnostic method. Furthermore, Polarean Imaging plc is actively involved in the design and manufacturing of the specific MRI radiofrequency coils that are indispensable for imaging 129Xe within an MRI system. Established in 2016, the company's base of operations is located in Durham, North Carolina.